Business Insider

Ofev (nintedanib) - Drug Insight and Market Forecast - 2030

New York, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Ofev (nintedanib) - Drug Insight and Market Forecast - 2030" - https ...
FiercePharma

Boehringer Ingelheim's Ofev scores FDA nod as first treatment for rare lung disease

Boehringer Ingelheim rode rare lung disease med Ofev to serious sales growth last quarter, and it’s looking to keep that trend going. Could a new, competition-free lung disease indication be the boost ...
Drug Store News

Glenmark obtains FDA tentative nod for generic Ofev

Glenmark has received tentative approval from the Food and Drug Administration for nintedanib capsules in dosage strengths of 100 mg and 150 mg. The medication is the generic of Boehringer Ingelheim’s ...
Medical Xpress

Esbriet, ofev approved to treat deadly lung disease

(HealthDay)—Two new drugs have been approved by the U.S. Food and Drug Administration to treat progressive lung scarring from an uncertain cause, medically called idiopathic pulmonary fibrosis (IPF).
WKRG

U.S. FDA accepts supplemental New Drug Application for OFEV® (nintedanib) for children and adolescents aged 6-17 years old with fibrosing interstitial lung disease

RIDGEFIELD, Conn. and INGELHEIM, Germany, July 25, 2023 /PRNewswire/ -- Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) accepted its supplemental New Drug ...
Fierce Pharma

BI's Jascayd quickly expands lung disease reach with new FDA nod

Just two months after reviving its prowess in the idiopathic pulmonary fibrosis (IPF) treatment area with rare lung disease med Jascayd, Boehringer Ingelheim is already unlocking another patient po | ...